MedTrace Logo

REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)

NCT00640991 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2010-06-16

No results posted yet for this study

Summary

Insulin will safely reduce glucose levels in patients with acute ST-elevation myocardial infarction and admission hyperglycemia.

Conditions

Interventions

DRUG

glulisine insulin, glargine insulin

IV infusion of glulisine, SC injection of glargine

Sponsors & Collaborators

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Hertzel Gerstein, MD, MSc, FRCPC · McMaster University

  • Salim Yusuf, DPhil, FRCPC, FRSC · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Argentina
  • Canada
  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00640991 on ClinicalTrials.gov